Skip to main content

Comorbid overweight/obesity and chronic pancreatitis exacerbate the dyslipidemia progression in type 2 diabetic patients Cover

.blurhash-client-img { display: none !important; }

Comorbid overweight/obesity and chronic pancreatitis exacerbate the dyslipidemia progression in type 2 diabetic patients

Endocrine Regulations

Volume 56 (2022): Issue 3 (July 2022)

By: Mariya Marushchak, Kateryna Kozak and Inna Krynytska

Open Access

|Jul 2022

Metrics

Articles in this issue

DOI: https://doi.org/10.2478/enr-2022-0018 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 168 - 177

Published on: Jul 13, 2022

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

type 2 diabetes mellitus,

overweight/obesity,

chronic pancreatitis,

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2022 Mariya Marushchak, Kateryna Kozak, Inna Krynytska, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 56 (2022): Issue 3 (July 2022)

Previous article